Management and Outcomes of Intracerebral Hemorrhage

Spontaneous intracerebral haemorrhage (ICH) represents a devastating form of stroke with high mortality and long-term disability. Management focuses on rapid identification, stabilisation and prevention of haematoma growth, followed by strategies to limit secondary brain injury. Acute care includes intensive blood pressure lowering, reversal of anticoagulation, management of raised intracranial pressure and critical-care support. In selected cases, surgical evacuation—ranging from open craniotomy to minimally invasive catheter techniques—may reduce mass effect and improve recovery. Despite these measures, functional outcomes remain poor for many patients, reflecting complex pathophysiology including perihaematomal inflammation, oedema and neuronal injury. Recent advances in prognostic modelling and imaging biomarkers have refined risk stratification, while emerging therapies targeting coagulation, neuroinflammation and neuroprotection hold promise for improving long-term functional independence.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Management and Outcomes of Intracerebral Hemorrhage publication trend

The graph below shows the total number of articles in management and outcomes of intracerebral hemorrhage across all publications each year (not limited to Nature Index journals).

Technical terms

Modified Rankin Scale: An ordinal scale (0–6) measuring functional independence and disability after stroke.

Care bundle: A structured set of evidence-based interventions applied together to improve patient outcomes.

Haematoma expansion: Increase in intracerebral blood volume after initial bleed, associated with worse prognosis.

Minimally invasive catheter evacuation: A percutaneous technique using small bore catheters and thrombolytics to remove intracerebral clots.

Spot sign: A contrast extravasation marker on CT angiography indicating active bleeding and risk of haematoma growth.

References

1. The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial. The Lancet (2023).
2. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. The Lancet (2018).
3. Surgery for spontaneous intracerebral hemorrhage. Critical Care (2020).
4. Expert-level detection of acute intracranial hemorrhage on head computed tomography using deep learning. Proceedings of the National Academy of Sciences of the United States of America (2019).
5. Advanced machine learning in action: identification of intracranial hemorrhage on computed tomography scans of the head with clinical workflow integration. npj Digital Medicine (2018).